Clinical Trials Directory

Trials / Sponsors / Zhou Chengzhi

Zhou Chengzhi

Academic / Other · 11 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
RecruitingDiagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis
Checkpoint Inhibitor-related Pneumonitis
—2026-01-10
Not Yet RecruitingAuto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC
Extensive Stage Small Cell Lung Cancer
Phase 1 / Phase 22024-12-01
Active Not RecruitingOnco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
Respiratory, Epidemiology, Neoplasms
—2024-09-05
RecruitingSafety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers
Lung Cancer
Phase 1 / Phase 22024-09-01
Not Yet RecruitingLiposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
Small Cell Lung Cancer
N/A2024-07-05
RecruitingEfficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC
Lung Cancer
Phase 32024-03-01
UnknownPirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
Pneumonitis, Malignant Tumor
Phase 12021-10-10
UnknownInvestigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC
Biomarkers
—2021-06-01
CompletedEfficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma
Lung Adenocarcinoma Stage IV
Phase 22021-03-01
UnknownChemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC
Extensive Stage Small Cell Lung Cancer
Phase 12021-01-27
UnknownClinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primar
Primary Pulmonary Lymphoepithelioma-like Carcinoma, Lung Cancer
Phase 22020-03-01